Ticker: TSHA

Company: Taysha Gene Therapies, Inc.

Person: Sukumar Nagendran, director, officer

Transaction date: Jan. 12, 2026

Reporting date: Jan. 14, 2026

Average share price: -1.6687580711943795

Sold 427000.0 shares for 712559.7